News
GSK cements Blenrep comeback with MHRA approval
GSK's Blenrep has nearly completed its winding road as the multiple myeloma drug receives approval for second-line us in the UK.
News
Merida raises $121m for Graves drug, and other financings
Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
Oncology
The complement system: The driving force behind a new genera...
Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease.
News
Scancell taps into NHS matchmaking service for cancer trial
Scancell is using a new service launched by the NHS to pair patients with suitable clinical trials in a phase 2 trial of its melanoma cancer vaccine.
News
BMS gets another FDA okay for Opdivo/Yervoy combo
Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
